Endoscopic POR is generally considered to precede clinical recurrence and has been reported to occur in 58%-72% of patients within 1 year postoperatively (4) . The mucosa proximal to the intestinal anastomosis (neoterminal ileum) is at a particularly high risk of recurrence. Endoscopic POR can be quantified using Rutgeerts endoscopic score, and endoscopy-based management can be applied (5) . Based on this score, five recurrence risk groups have been defined (Table 1) . Endoscopic recurrence is generally defined as Rutgeerts score of ≥i2 (5) .
In the present article, a retrospective single-center study was conducted; it included 42 patients with CD who had undergone ileocolic resection between 2003 and 2014 (6) . The endoscopic POR rate within 6-12 months after ileocolic resection was 59.5% (25 of 42 patients). This recurrence rate was comparable with that in other studies that have reported endoscopic recurrence rates in 54%-75% of patients within 1 year after surgical resection (6) . Currently, there is no agreement on the optimal approach to reduce POR in patients with CD. Patient stratification according to Rutgeerts scoring system is still the cornerstone in patients with CD within the first year after surgical resection (5) . As the result of endoscopy is obtained within 6-12 months after surgery, it does not help physicians determine the best therapeutic approach during the early postoperative period. During this period, some predictive factors can be used to discriminate high-risk patients (7). Smoking, prior intestinal resection, penetrating disease behavior, perianal disease, extensive bowel disease (>50 cm), preoperative corticosteroid use, postoperative immunomodulatory or biologic medical treatment, the presence of granulomas, myenteric plexitis, and fecal calprotectin have been found to be risk factors for POR (1, 2, 4, (7) (8) (9) . However, the POCER trial, in which smoking, penetrating disease behavior, and prior intestinal resection were accepted as high 
